Arc­turus touts $63M BAR­DA award for new mR­NA in­fluen­za vac­cine, hop­ing to prep against fu­ture pan­demics

A San Diego mR­NA biotech is look­ing to ex­pand its ef­forts in in­fluen­za, and a fed­er­al award will bring it clos­er to that goal.

Arc­turus Ther­a­peu­tics said Wednes­day that it won an award from HHS’s BAR­DA worth $63.2 mil­lion, a grant that was award­ed as part of the en­ti­ty’s pan­dem­ic in­fluen­za ef­forts. The grant will be divvied out over the next three years to boost Arc­turus’ self-am­pli­fy­ing mR­NA vac­cine plat­form tech on mul­ti­ple as­pects, such as pre­clin­i­cal re­search, man­u­fac­tur­ing, non-clin­i­cal safe­ty stud­ies and reg­u­la­to­ry sup­port.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER